Telesis Bio (TBIO) Competitors $0.02 0.00 (0.00%) As of 08/1/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock TBIO vs. SMIT, SPEC, THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, and KEYSShould you be buying Telesis Bio stock or one of its competitors? The main competitors of Telesis Bio include Schmitt Industries (SMIT), Spectaire (SPEC), ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), and Keysight Technologies (KEYS). These companies are all part of the "measuring and control equipment" industry. Telesis Bio vs. Its Competitors Schmitt Industries Spectaire ThermoGenesis HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Telesis Bio (NASDAQ:TBIO) and Schmitt Industries (NASDAQ:SMIT) are both small-cap measuring and control equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation. Which has higher earnings & valuation, TBIO or SMIT? Schmitt Industries has lower revenue, but higher earnings than Telesis Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTelesis Bio$225.09M0.00-$47.72M-$28.200.00Schmitt Industries$9.89M0.01-$3.28MN/AN/A Is TBIO or SMIT more profitable? Schmitt Industries has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Company Net Margins Return on Equity Return on Assets Telesis Bio-336.59% N/A -61.89% Schmitt Industries N/A N/A N/A Does the media prefer TBIO or SMIT? In the previous week, Telesis Bio's average media sentiment score of 0.00 equaled Schmitt Industries'average media sentiment score. Company Overall Sentiment Telesis Bio Neutral Schmitt Industries Neutral Do insiders and institutionals hold more shares of TBIO or SMIT? 37.6% of Telesis Bio shares are held by institutional investors. 24.5% of Telesis Bio shares are held by insiders. Comparatively, 17.1% of Schmitt Industries shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility & risk, TBIO or SMIT? Telesis Bio has a beta of 2.89, meaning that its stock price is 189% more volatile than the S&P 500. Comparatively, Schmitt Industries has a beta of -0.3, meaning that its stock price is 130% less volatile than the S&P 500. SummaryTelesis Bio and Schmitt Industries tied by winning 4 of the 8 factors compared between the two stocks. Get Telesis Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TBIO vs. The Competition Export to ExcelMetricTelesis BioAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$40K$1.39M$5.49B$9.52BDividend YieldN/AN/A4.73%4.09%P/E Ratio0.00N/A28.7823.81Price / Sales0.004.56372.2066.04Price / CashN/AN/A35.4557.96Price / Book0.160.108.275.54Net Income-$47.72M-$54.87M$3.25B$259.28M7 Day PerformanceN/A6.38%-3.70%-4.64%1 Month PerformanceN/A7.14%4.34%4.41%1 Year PerformanceN/A-83.15%25.90%17.95% Telesis Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TBIOTelesis BioN/A$0.02flatN/A-99.5%$40K$225.09M0.00200Upcoming EarningsSMITSchmitt IndustriesN/A$0.02-16.6%N/AN/A$69K$9.89M0.00160SPECSpectaireN/A$0.00flatN/A-99.9%$6KN/A0.008THMOThermoGenesis0.2298 of 5 stars$0.00+∞N/A-99.9%$1K$9.61M0.0040Gap UpHTGMQHTG Molecular DiagnosticsN/AN/AN/A-93.3%$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.11-5.9%N/A-9.1%$0.00N/A0.003PRENWPrenetics GlobalN/A$0.03-14.1%N/A+261.6%$0.00$41.52M0.001Positive NewsGap DownQSIAWQuantum-SiN/A$0.58-0.9%N/A+168.1%$0.00$3.44M0.00150Positive NewsGap DownSMAPWSportsMap Tech AcquisitionN/A$0.03-30.3%N/AN/A$0.00N/A0.00N/AGap DownTTTrane Technologies3.9042 of 5 stars$472.45+0.1%$441.40-6.6%+31.7%$105.28B$19.84B39.3145,000Trending NewsEarnings ReportAnalyst DowngradeShort Interest ↑KEYSKeysight Technologies4.3752 of 5 stars$166.58+0.1%$187.50+12.6%+19.7%$28.65B$4.98B39.1015,500News CoveragePositive NewsGap Down Related Companies and Tools Related Companies Schmitt Industries Competitors Spectaire Competitors ThermoGenesis Competitors HTG Molecular Diagnostics Competitors OmniLit Acquisition Competitors Prenetics Global Competitors Quantum-Si Competitors SportsMap Tech Acquisition Competitors Trane Technologies Competitors Keysight Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TBIO) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telesis Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telesis Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TBIO Stock Alerts